Xiong Liu

Xiong Liu, Director of Data Science and AI at Novartis, shares his expertise in modernizing clinical trials with AI. He discusses how AI streamlines data workflows and enhances study readiness while ensuring regulatory compliance. The conversation highlights the shift towards decentralized trials, the innovative use of AI to predict COVID-19 patient outcomes, and the transformative power of federated learning in healthcare. Liu emphasizes the importance of integrating diverse data sources and building patient trust as AI reshapes drug development.